Metraipolis › archive › dc_220eb12cfa42

Surveillance and vaccine effectiveness of pertussis, the Netherlands, 2012 to 2024, with an unprecedented surge in 2023 and 2024 — Europe PMC PMID:42141889

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42141889
DOI
10.2807/1560-7917.es.2026.31.15.2500919
License (as archived)
solo-consultazione
Archived
2026-11-03T13:33:50.439Z
SHA-256 of the archived text
d9cf17dd77a97c9c109d23bbdf1ef8389fad0bd6118212f9079be6a705a8cb7f
Stable URL of this page
https://metraipolis.com/documento/dc_220eb12cfa42

How to cite

Surveillance and vaccine effectiveness of pertussis, the Netherlands, 2012 to 2024, with an unprecedented surge in 2023 and 2024 — Europe PMC PMID:42141889 — Europe PMC (en), https://europepmc.org/article/MED/42141889 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_220eb12cfa42 (Metraipolis archive dc_220eb12cfa42, sha256 d9cf17dd77a97c9c109d23bbdf1ef8389fad0bd6118212f9079be6a705a8cb7f)
BibTeX
@misc{dc220eb12cfa42,
  title = {Surveillance and vaccine effectiveness of pertussis, the Netherlands, 2012 to 2024, with an unprecedented surge in 2023 and 2024 — Europe PMC PMID:42141889},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42141889},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_220eb12cfa42; sha256 d9cf17dd77a97c9c109d23bbdf1ef8389fad0bd6118212f9079be6a705a8cb7f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42141889. Agents can read the archived copy with the MCP tool read_document.